CMS certification 140150
University of Illinois Hospital and Clinics
1740 West Taylor St Suite 1400, Chicago, IL 60612
University of Illinois Hospital and Clinics has a CMS overall rating of 4 out of 5 stars. 65% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on none. Emergency patients spend a median of 4 h 58 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 931 completed surveys, 9% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | IL | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 336 visits sampled · US median for EDs of the same volume: 3 h 22 min | 4 h 58 min | 2 h 42 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 18 visits sampled | 11 h 24 min | 4 h 48 min | 4 h 17 min |
| Left before being seen Lower is better · 53,941 patients | 4% | 3% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 130 patients | 57% | 63% | 65% |
How University of Illinois Hospital and Clinics compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| University of Illinois Hospital and ClinicsThis hospital | 4/5 | 65% | 4 h 58 min | 4 better |
| Jesse Brown VA Medical Center - VA Chicago Healthcare SystemSame city | 4/5 | 68% | — | 3 better |
| John H Stroger Jr HospitalSame city | 2/5 | 68% | 4 h 53 min | 1 better 1 worse |
| Rush University Medical CenterSame city | 5/5 | 77% | 6 h 10 min | 8 better 3 worse |
| Northwestern Memorial HospitalSame city | 5/5 | 81% | 5 h 50 min | 9 better 3 worse |
| Thorek Memorial HospitalSame city | Not rated | 70% | 2 h 54 min | 1 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Chicago.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 1,414 cases | Too few cases | 3.3% | 3.9% |
| Heart attack 26 cases | Too few cases | 11.6% | 11.9% |
| Heart failure 150 cases | Too few cases | 10.1% | 11.1% |
| Pneumonia 89 cases | Too few cases | 11.3% | 15.2% |
| Stroke 200 cases | Too few cases | 9.4% | 11.9% |
| COPD 44 cases | Too few cases | 8.2% | 8.6% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.13 likely 0.85 – 1.42 | 1 |
| After hip or knee replacement 50 cases | Too few cases | 4.5% | 4.1% |
| Deaths after a serious but treatable surgical complication 97 cases | No different | 179.54 per 1,000 likely 131 per 1,000 – 228.08 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 3,923 cases | No different | 0.78 per 1,000 likely 0.16 per 1,000 – 1.41 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 4,308 cases | No different | 0.23 per 1,000 likely 0.01 per 1,000 – 0.44 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 4,585 cases | No different | 0.22 per 1,000 likely 0.02 per 1,000 – 0.42 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,194 cases | No different | 3.07 per 1,000 likely 1.72 per 1,000 – 4.43 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 462 cases | No different | 1.37 per 1,000 likely 0 per 1,000 – 2.93 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 604 cases | No different | 12.02 per 1,000 likely 6.54 per 1,000 – 17.5 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,289 cases | No different | 4.89 per 1,000 likely 2.78 per 1,000 – 7 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 579 cases | No different | 4.43 per 1,000 likely 1.24 per 1,000 – 7.63 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 492 cases | No different | 1.54 per 1,000 likely 0.11 per 1,000 – 2.97 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,194 cases | No different | 1.03 per 1,000 likely 0.08 per 1,000 – 1.99 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.62 likely 0.29 – 1.18 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.38 likely 0.15 – 0.79 | 1 |
| Surgical site infections after colon surgery | No different | 0.54 likely 0.14 – 1.46 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 1.43 likely 0.24 – 4.72 | 1 |
| MRSA bloodstream infections | Better | 0.15 likely 0.03 – 0.5 | 1 |
| C. diff intestinal infections | Better | 0.27 likely 0.16 – 0.44 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 63 cases | Too few cases | 14.6% | 14.4% |
| Readmitted after heart failure 339 cases | Too few cases | 21.5% | 21.3% |
| Readmitted after pneumonia 180 cases | Too few cases | 17.6% | 17.3% |
| Readmitted after COPD 119 cases | Too few cases | 19.7% | 20% |
| Readmitted after heart bypass surgery 27 cases | Too few cases | 12.2% | 11% |
| Readmitted after hip or knee replacement 55 cases | Too few cases | 7.4% | 5.8% |
| Days back in hospital after heart failure 181 cases | Too few cases | 42.6 days per 100 | — |
| Days back in hospital after pneumonia 92 cases | Too few cases | 31.7 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 541 cases | No different | 13.7 per 1,000 likely 10.2 per 1,000 – 18.2 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 155 cases | No different | 10.5 per 100 likely 7.7 per 100 – 14.1 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 155 cases | No different | 5.1 per 100 likely 3.5 per 100 – 7.6 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 193 cases | No different | 0.9 likely 0.7 – 1.2 | — |
2 more measures had too few cases here to report.
Clinicians registered at this address
1,082 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 252 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Internal Medicine | 115 |
| Anesthesiology | 101 |
| Emergency Medicine | 99 |
| Pediatrics | 43 |
| Nurse Anesthetist, Certified Registered | 41 |
| Diagnostic Radiology | 33 |
| Family Medicine | 32 |
| Obstetrics & Gynecology | 32 |
| Pharmacist | 31 |
| Family | 29 |
| Psychiatry | 28 |
| Neurology | 27 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $6.2M
- 2020 $7.1M
- 2021 $8.5M
- 2022 $7.6M
- 2023 $10.2M
- 2024 $16.5M
- 2025 $16M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $1.6M | 36 |
| Space rental and facility fees | $1.3M | 75 |
| Education | $532,743 | 30 |
| Medical devices and supplies on long-term loan | $525,828 | 35 |
| Consulting fees | $118,979 | 23 |
| Speaking, teaching and other services | $67,358 | 29 |
| Royalties and licensing fees | $6,209 | 11 |
| Gifts | $1,200 | 1 |
| Debt forgiveness | $432 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Novartis Pharmaceuticals Corporation | $7.4M | 5 |
| Intuitive Surgical, INC. | $1.2M | 66 |
| Takeda Pharmaceuticals U.S.A., Inc. | $815,884 | 57 |
| Pfizer INC. | $759,945 | 17 |
| Abbvie INC. | $628,584 | 122 |
| Medtronic, Inc. | $545,332 | 38 |
| Genentech, Inc. | $457,819 | 26 |
| Gilead Sciences, Inc. | $420,591 | 7 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| Ribociclib and endocrine treatment of physician's choice for logoregional recurrent, resected hormone receptor positive HER2 negative breast cancer (… Novartis Pharmaceuticals Corporation | $7.3M |
| EFFECTS OF GBT601 ON KIDNEY AND CARDIOPULMONARY FUNCTION IN TRANSGENIC SICKLE CELL MICE PFIZER INC. | $300,000 |
| A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Dur… AstraZeneca Pharmaceuticals LP | $232,807 |
| A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Pos… Merck Sharp & Dohme LLC | $180,119 |
| A Phase 3, Open Label, Multicenter, Randomized Study of First Line Tarlatamab in Combination With Durvalumab, Carboplatin and Etoposide Versus Durval… Amgen Inc. | $141,099 |
| The African American Heart Study: A Real-World Data Study of Atherosclerotic Cardiovascular Risk in African American and Black Participants in the US Amgen Inc. | $126,020 |
| Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC) Head and Neck Squamous Cell Carcino… ABBVIE INC. · NCT05005403 | $122,386 |
| Assessment Neurovascular Dysfunction Early Retinopathy (ANALYSER) Regeneron Pharmaceuticals, Inc. | $103,230 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about University of Illinois Hospital and Clinics
Is University of Illinois Hospital and Clinics a good hospital?
University of Illinois Hospital and Clinics has a CMS overall rating of 4 out of 5 stars. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on none. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend University of Illinois Hospital and Clinics?
65% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 931 completed HCAHPS surveys.
How long is the wait in the University of Illinois Hospital and Clinics emergency room?
Emergency patients spend a median of 4 h 58 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with high patient volume, like this one, the median is 3 h 22 min. 4% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does University of Illinois Hospital and Clinics receive money from drug and device companies?
Drug and device makers reported $16M in payments to University of Illinois Hospital and Clinics for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.